Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Thursday, December 18, 2014

US stock market daily report

One of the world's most expensive cancer drugs will go on sale Thursday, courtesy of the worlds largest biotech company, Amgen Inc. . The drug - Blincyto - is a new treatment for a deadly form of blood cancer called acute lymphoblastic leukemia , will cost about $178,000 for two courses of treatment at $89,000 per cycle.

http://ift.tt/13B9eJm

No comments:

Post a Comment

Popular Stem Cell Roundup Posts